Darmstadt, Germany (ots/PRNewswire) - - New pen is easy-to-learn and easy-to-use, supporting the one in six couples affected by infertility in the U.S.[1] - Insights of patients, nurses and doctors helped to evolve the product Merck, a leading science and technology company, today announced that the company received approval for a new version of GONAL-f® (follitropin alfa injection) prefilled pen from the U.S. Food and ...
Amsterdam (ots/PRNewswire) - myTomorrows announces that Ronald Plasterk, a renowned molecular geneticist and until recently Dutch Minister of the Interior and Kingdom Relations, joins the company as Chief Scientific Officer, effective 1 December 2017. Plasterk will primarily focus on creating academic partnerships to address specific areas of unmet medical need, supporting myTomorrows' aim to facilitate early access to ...
Frankfurt am Main (ots) - - Representative survey: respondents agree change is necessary - High willingness to change personal behaviour also confirmed - One in three respondents has already changed their mobility behaviour - Scepticism towards e-mobility still widespread In the face of increasingly congested roads, ...
Karlsruhe (ots) - Creative automotive multimedia set to reach new heights in performance and originality as Cinemo middleware deliver unprecedented content control to Renesas R-Car Systems-on-Chip Cinemo, a global leader in high performance and automotive grade multimedia playback, streaming, media management, connectivity and cloud access middleware, today announced ...
Reading, England (ots/PRNewswire) - /OFF HOLD OFF HOLD OFF HOLD -- European Centre for Medium-Range Weather Forecasts, PIV890504 The following release: "New Seasonal Prediction System SEAS5 Brings Better El Niño Forecasts" is now OFF HOLD. Distribution time: 10 Nov 2017 00:01 GMT The European Centre for Medium-Range Weather Forecasts (ECMWF) today launches its latest ...
JTI Japan Tobacco International AG
Geneva (ots/PRNewswire) - JTI Calls for Continued Coordinated Approach in the Interest of Tobacco Growing Communities JTI (Japan Tobacco International) commends the Governing Body of the International Labour Organization (ILO) for postponing its decision on the continuation of the ILO's partnerships with the tobacco sector in the fight against child labor. ARISE ...
Montréal (ots/PRNewswire) - 40% of executives have an enterprise-wide digital strategy in place, up from 12% in 2016 CGI (TSX: GIB.A) (NYSE: GIB) released its 2017 CGI Client Global Insights, which demonstrate an increased urgency among business and IT leaders to transform to meet the digital expectations of their ...
Darmstadt, Germany (ots/PRNewswire) - - First multiple sclerosis (MS) therapy to achieve positive NICE recommendation in the shortest possible timeframe - Mavenclad has shown sustained clinical efficacy up to four years with a maximum of 20 days of oral treatment over two years Merck, a leading science and technology company, today announced that the National Institute ...
http://resources.euroadhoc.com/images/11/5/10073235/_56A5599_A.jpg issuer: Rosenbauer International AG Paschingerstrasse 90 A-4060 Leonding phone: +43(0)732 6794 568 FAX: +43(0)732 6794 89 mail: ir@rosenbauer.com WWW: www.rosenbauer.com ISIN: AT0000922554 indexes: WBI stockmarkets: Wien, Berlin, Stuttgart ...
Zurich (ots/PRNewswire) - Neurimmune, a global leader in the discovery and development of human-derived monoclonal antibodies, today announced that it has entered into a collaboration with Ono Pharmaceutical Co., Ltd. focused on the development of human antibodies against a novel therapeutic target for neurodegenerative diseases. Under the terms of the collaboration ...
Stockholm (ots/PRNewswire) - OxThera AB announced today that it has recently been granted two new US patents, three new European patents and patents in Canada, China, Hong-Kong, India and Japan. OxThera now holds proprietary rights to pharmaceutical preparations and their use for treatment of hyperoxaluria in nine patent families. The newly granted US patents have ...
EQS Group-Ad-hoc: Leclanché SA / Key word(s): Investment/Financing Leclanché SA: EPAL Partners with Leclanché and Deltro and Invests US $12 million in First Utility-scale Canadian Energy Storage Project 08-Nov-2017 / 18:27 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 KR The issuer is solely ...
Toronto (ots/PRNewswire) - Richmont Mines Inc. (TSX: RIC) (NYSE: RIC) ("Richmont" or the "Corporation") announces operating and financial results for the three and nine months ended September 30, 2017. (All amounts are in Canadian dollars, unless otherwise indicated.) THIRD QUARTER AND NINE-MONTH HIGHLIGHTS - ...
issuer: voestalpine AG voestalpine-Straße 1 A-4020 Linz phone: +43 50304/15-9949 FAX: +43 50304/55-5581 mail: IR@voestalpine.com WWW: www.voestalpine.com ISIN: AT0000937503 indexes: WBI, ATX stockmarkets: Wien language: English ...
Beerse, Belgium (ots/PRNewswire) - FOR MEDICAL AND TRADE MEDIA ONLY - 60% of patients receiving ustekinumab showed significant reductions in lupus disease activity vs. 31% of patients receiving placebo - Ustekinumab showed significant improvements in various disease measures compared with placebo, including ...
Beerse, Belgium (ots/PRNewswire) - FOR MEDICAL AND TRADE MEDIA ONLY Longer-term results demonstrate continued efficacy of anti-interleukin 23 monoclonal antibody guselkumab in improving joint and skin symptoms associated with active psoriatic arthritis Janssen Research & Development, LLC (Janssen) announced today ...
issuer: ams AG Tobelbader Strasse 30 A-8141 Premstaetten phone: +43 3136 500-0 FAX: +43 3136 500-931211 mail: investor@ams.com WWW: www.ams.com ISIN: AT0000A18XM4 indexes: stockmarkets: SIX Swiss Exchange language: English ...
Beerse, Belgium (ots/PRNewswire) - FOR MEDICAL AND TRADE MEDIA ONLY Longer-term results demonstrate continued efficacy of anti-interleukin 23 monoclonal antibody guselkumab in improving joint and skin symptoms associated with active psoriatic arthritis Janssen Research & Development, LLC (Janssen) announced today ...
Beerse, Belgium (ots/PRNewswire) - FOR MEDICAL AND TRADE MEDIA ONLY - 60% of patients receiving ustekinumab showed significant reductions in lupus disease activity vs. 31% of patients receiving placebo - Ustekinumab showed significant improvements in various disease measures compared with placebo, including ...
Berlin (ots/PRNewswire) - - 'Vaccination apathy' is a key barrier to protecting the community against infectious disease, according to global health experts - By 2060, 30% of Europeans will be aged 65 years or over[1] - a life-course approach to immunisation, including adult vaccination, is a cost-effective method ...
AT & S Austria Technologie und Systemtechnik Aktiengesellschaft
issuer: AT & S Austria Technologie und Systemtechnik Aktiengesellschaft Fabriksgasse 13 A-8700 Leoben phone: 03842 200-0 FAX: mail: e.koch@ats.net WWW: www.ats.net ISIN: AT0000969985 indexes: ATX GP, VÖNIX, WBI stockmarkets: Wien language: English ...
San Diego and London (ots/PRNewswire) - Findings from a new multi-country GSK survey, released today to coincide with the 2017 American College of Rheumatology/Association for Rheumatology Health Professionals Annual Meeting (ACR/AHRP), reveal that patients with systemic lupus erythematosus (SLE) often self-manage ...
Toronto (ots/PRNewswire) - Alamos Gold Inc. ("Alamos") (TSX: AGI) (NYSE: AGI) and Richmont Mines Inc. ("Richmont") (TSX: RIC) (NYSE: RIC) today announced that Institutional Shareholder Services Inc. ("ISS") and Glass, Lewis & Co., LLC ("Glass Lewis"), two leading proxy advisory firms, have recommended that both ...
Glasgow, Scotland (ots/PRNewswire) - Poster Presentation PDB27 A new analysis of real-world data has shown that switching to Tresiba® (insulin degludec) is highly cost-effective and cost-saving for the treatment of type 1 and type 2 diabetes, respectively.[1] The analysis was presented today at the International Society for Pharmacoeconomics and Outcomes Research ...
Lausanne, Switzerland (ots) - The clinical trial is in collaboration with the Merck-Pfizer Alliance Debiopharm International SA (Debiopharm - www.debiopharm.com), part of Debiopharm Group(TM), a Swiss-based global biopharmaceutical company, today announced the dosing of the first patient in a Phase Ib study of Debio ...
London (ots/PRNewswire) - First Derivatives plc ("FD" or the "Group") FD (AIM:FDP.L, ESM:FDP.I) announces that it has been selected by Red Bull Racing as a team supplier for the use of its Kx technology to analyse sensor data from its Formula 1 vehicles. Initially, Kx will be deployed for the analysis of wind tunnel data, a critical element in the development of faster, more competitive F1 cars. (Logo: ...
London, Geneva, Amsterdam and Stavanger, Norway (ots/PRNewswire) - In a unique collaboration, several of the world's largest trading houses, integrated energy companies and banks intend to create and invest in a new venture, which will be managed and operated as an independent entity. The new venture will develop a ...
EQS Group-Ad-hoc: Leclanché SA / Key word(s): Contract/Development of Sales Leclanché SA: Leclanché receives order for a 15 MWh battery storage project from swb in Germany 06-Nov-2017 / 07:30 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 KR The issuer is solely responsible for the content of ...
issuer: Andritz AG Stattegger Straße 18 A-8045 Graz phone: +43 (0)316 6902-0 FAX: +43 (0)316 6902-415 mail: welcome@andritz.com WWW: www.andritz.com ISIN: AT0000730007 indexes: ATX, WBI stockmarkets: Wien language: English ...
EQS Group-Ad-hoc: VZ Holding AG / Key word(s): Miscellaneous VZ Holding AG: VZ Group increases provisions for tax claims 03-Nov-2017 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 KR The issuer is solely responsible for the content of this announcement. 624631 03-Nov-2017 CET/CEST ...